share_log

新銳醫藥：董事會會議召開日期

NEW RAY MEDIC: DATE OF BOARD MEETING

香港交易所 ·  Mar 13 08:04
Summary by Moomoo AI
新銳醫藥國際控股有限公司（「新锐医药」）將於2024年3月25日（星期一）召開董事會會議，屆時將考慮及批准截至2023年12月31日止年度的全年業績及其刊發。會議同時將考慮是否派付末期股息。新锐医药的執行董事包括王秋勤女士、霍志宏先生、禇雪平先生及周灣女士，獨立非執行董事則為梁志堅先生、李倩明女士及施禮賢先生。
新銳醫藥國際控股有限公司（「新锐医药」）將於2024年3月25日（星期一）召開董事會會議，屆時將考慮及批准截至2023年12月31日止年度的全年業績及其刊發。會議同時將考慮是否派付末期股息。新锐医药的執行董事包括王秋勤女士、霍志宏先生、禇雪平先生及周灣女士，獨立非執行董事則為梁志堅先生、李倩明女士及施禮賢先生。
NEW SHARP PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (“NEW SHARP PHARMACEUTICALS”) WILL HOLD A BOARD MEETING ON MONDAY, 25 MARCH 2024 TO CONSIDER AND APPROVE THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 AND THEIR PUBLICATION. The meeting will also consider whether to pay a final dividend. The Executive Directors of XinQi Pharmaceuticals include Ms. Wang Qiu Qin, Mr. Ho Chi Hong, Mr. Xue Ping and Ms. Zhou Wan. The Independent Non-Executive Directors are Mr. Leung Chi Kin, Ms. Lee Sian Ming and Mr. Shi Lai Yin.
NEW SHARP PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (“NEW SHARP PHARMACEUTICALS”) WILL HOLD A BOARD MEETING ON MONDAY, 25 MARCH 2024 TO CONSIDER AND APPROVE THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 AND THEIR PUBLICATION. The meeting will also consider whether to pay a final dividend. The Executive Directors of XinQi Pharmaceuticals include Ms. Wang Qiu Qin, Mr. Ho Chi Hong, Mr. Xue Ping and Ms. Zhou Wan. The Independent Non-Executive Directors are Mr. Leung Chi Kin, Ms. Lee Sian Ming and Mr. Shi Lai Yin.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more